— Know what they know.
Not Investment Advice

PHVS Earnings

Pharvaris N.V.
1W: +3.4% 1M: +0.1% 3M: -2.0% YTD: +20.7% 1Y: +39.0% 3Y: +84.8% 5Y: +109.9%
$31.95
+0.41 (+1.30%)
 
Weekly Expected Move ±6.2%
$28 $29 $31 $33 $35
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $2.2B mcap · 34M float · 2.08% daily turnover · Short 51% of daily vol
Credit Risk of going bust: lower than 93% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), Pharvaris N.V. would be worth roughly what it owes.
Total debt $750K against a stock market value of $2.23B.
Distance to default 16.25 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $375K (short-term plus half of long-term), stock volatility 52.9%; Altman Z'' 7.15. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Last Earnings 2026-08-12
EPS
€-0.81 (US$-0.90)
▼ Miss -8.5%
Revenue
—
Next Earnings 2026-11-11
EPS Estimate
€-0.77 (US$-0.86)
Range: €-0.87 - €-0.70
Revenue Estimate
€7M ($7M)
7 analysts
1 USD = 0.90 EUR

Estimate vs Actual

Earnings Surprise History

6/18
EPS Beats
0/18
Revenue Beats
33%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-26 annual 2030-12-31 €5.01 €5.00 ▼ 0.01 €859,488,501 €858,310,102
2026-10-26 annual 2026-12-31 €-2.81 €-2.81 — €1,138,644 €1,138,644
2026-10-26 quarter 2027-03-30 €-0.80 €-0.80 — €1,524,953 €1,524,953
2026-10-26 annual 2027-12-31 €-2.72 €-2.72 — €33,070,081 €33,024,741
2026-10-26 quarter 2027-12-30 €-0.63 €-0.62 ▲ 0.01 €20,598,308 €20,570,067
2026-10-26 quarter 2027-06-30 €-0.78 €-0.78 — €2,004,030 €2,001,282
2026-10-26 annual 2028-12-31 €-0.87 €-0.87 — €222,141,984 €221,837,417
2026-10-26 quarter 2027-09-30 €-0.75 €-0.75 — €5,965,776 €5,957,597
2026-10-26 quarter 2026-12-30 €-0.78 €-0.77 ▲ 0.01 €6,728,820 €6,728,820
2026-10-26 annual 2029-12-31 €1.70 €1.70 — €522,654,694 €521,938,111
2026-10-23 annual 2029-12-31 €1.70 €1.70 — €522,873,392 €522,654,694
2026-10-23 annual 2026-12-31 €-2.81 €-2.81 — €1,138,644 €1,138,644
2026-10-23 quarter 2027-06-30 €-0.78 €-0.78 — €2,293,343 €2,004,030
2026-10-23 quarter 2027-03-30 €-0.80 €-0.80 — €1,524,953 €1,524,953
2026-10-23 annual 2028-12-31 €-0.87 €-0.87 — €222,234,936 €222,141,984
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms